Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jesus Berdeja

Jesus G. Berdeja MD

Director, Multiple Myeloma Research, Tennessee Oncology, Nashville, Tennessee

Jesus G. Berdeja received his undergraduate degree from Stanford University and medical degree from Harvard University.  He completed his internship and residency in the Department of Internal Medicine at the University of California in San Francisco and fellowships in medical oncology and hematology at Johns Hopkins University School of Medicine in Baltimore.  An active researcher, Dr. Berdeja has been the principal investigator of many funded clinical trials in the field of multiple myeloma and cellular therapy. He has published extensively in the peer-reviewed literature and is a frequent invited lecturer.


No disclosures reported.